MPH’s Schaffner optimistic about Zika Vaccine as First Local Outbreak Hits Florida
Researchers are one step closer to creating an approved Zika vaccine, with the first round of safety trials already underway. Drug companies have shown success in preclinical trials, in which they have induced immunity in mice and monkeys, indicating a greater likelihood that the vaccine could prevent infection in humans.
“In the last couple decades with modern microbiology, there’s been an explosion [in how quickly we] test vaccines,” Dr. William Schaffner, an infectious-diseases expert at Vanderbilt University Medical Center, told ABC News.